Skip to main content
Equibles
RNA logo

RNA · Atrium Therapeutics, Inc. · Held by Funds

Track RNA — free

Use RNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.36 +0.01 (+0.10%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$177.04M
Shares
17.11M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding RNA

158 fund positions
Fund Balance Value % of Fund Open
T. Rowe Price Health Sciences Fund, Inc. 566,428 $7,618,457 0.06%
VANGUARD TOTAL STOCK MARKET INDEX FUND 518,416 $6,972,695 0.00%
T. Rowe Price New Horizons Fund, Inc. 443,263 $5,961,887 0.04%
iShares Russell 2000 ETF 377,354 $5,075,411 0.01%
VANGUARD EXTENDED MARKET INDEX FUND 188,626 $2,537,020 0.00%
BlackRock Event Driven Equity Fund 175,388 $2,280,044 0.05%
Nexpoint Merger Arbitrage Fund 135,138 $1,817,606 0.12%
Fidelity Small Cap Index Fund 119,517 $1,526,232 0.00%
Janus Henderson Small Cap Growth Alpha ETF 118,267 $1,510,270 0.48%
iShares Russell 2000 Growth ETF 88,107 $1,185,039 0.01%
Fidelity Extended Market Index Fund 73,533 $955,929 0.00%
Schwab U.S. Small-Cap ETF 67,639 $879,307 0.00%
VANGUARD RUSSELL 2000 INDEX FUND 62,889 $817,557 0.00%
iShares Micro-Cap ETF 48,184 $648,075 0.04%
T. Rowe Price Health Sciences Portfolio 41,700 $560,865 0.07%
iShares Russell 2000 Value ETF 41,090 $552,661 0.00%
Master Small Cap Index Series 28,368 $381,550 0.01%
Fidelity Total Market Index Fund 26,529 $344,877 0.00%
Schwab Small-Cap Index Fund 26,564 $339,222 0.00%
Fidelity Series Total Market Index Fund 21,240 $276,120 0.00%
Goldman Sachs Small Cap Growth Insights Fund 21,214 $270,903 0.09%
iShares Core S&P Total U.S. Stock Market ETF 18,530 $249,229 0.00%
EQ/2000 Managed Volatility Portfolio 17,781 $239,154 0.01%
Putnam Dynamic Asset Allocation Growth Fund 14,908 $200,513 0.00%
Health Sciences Trust 14,900 $200,405 0.08%
Fidelity SAI Merger Arbitrage Fund 15,000 $191,550 0.03%
Goldman Sachs Small Cap Equity Insights Fund 14,269 $182,215 0.02%
AlphaCentric Life Sciences and Healthcare Fund 13,478 $181,279 0.39%
Nuveen Small Cap Blend Index Fund 14,100 $180,057 0.00%
BlackRock Advantage Small Cap Core Fund 12,237 $159,081 0.00%
Fidelity Enhanced Small Cap Core ETF 11,112 $149,456 0.00%
EQ/T.Rowe Price Health Sciences Portfolio 10,400 $139,880 0.08%
Goldman Sachs Small Cap Value Insights Fund 10,950 $139,832 0.01%
Putnam Dynamic Asset Allocation Balanced Fund 10,176 $136,867 0.00%
VANGUARD RUSSELL 2000 GROWTH INDEX FUND 10,524 $136,812 0.01%
Goldman Sachs Absolute Return Tracker Fund 10,078 $135,549 0.00%
NexPoint Event Driven Fund 10,033 $134,944 0.18%
Ultra-Small Company Market Fund 10,000 $134,500 0.09%
Fidelity Small Cap Growth Index Fund 9,178 $123,444 0.01%
Nuveen Equity Index Fund 9,612 $122,745 0.00%
Fidelity Nasdaq Composite Index Fund 8,998 $116,974 0.00%
EQ/Small Company Index Portfolio 8,380 $112,711 0.01%
VANGUARD TOTAL WORLD STOCK INDEX FUND 8,760 $111,865 0.00%
VANGUARD BALANCED INDEX FUND 8,159 $109,739 0.00%
Multi-Manager Small Cap Equity Strategies Fund 8,322 $108,186 0.01%
Schwab U.S. Broad Market ETF 8,226 $106,938 0.00%
LVIP State Street Small-Cap Index Fund 7,850 $105,583 0.00%
Small Cap Index Fund 7,436 $100,014 0.01%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND 6,870 $92,402 0.00%
Fidelity ZERO Total Market Index Fund 7,175 $91,625 0.00%
Showing 1–50 of 158 positions
Key facts CIK 2093101 CUSIP 04965N104 13F (30d) 91 filings 91 filers Visit website Investor relations